tegafur has been researched along with Fever in 8 studies
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients were eligible for the study if they had histologically documented gastric adenocarcinoma previously treated with paclitaxel and cisplatin, age > or = 18 years, Eastern Clinical Oncology Group performance status < or =2, adequate organ function, and no evidence of gastrointestinal obstruction or passage disturbance." | 5.14 | Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. ( Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, SJ; Shim, HJ; Yoon, JY, 2009) |
| ") gemcitabine (GEM) at low dose plus oral chemotherapy with uracil-tegafur (UFT) and cyclophosphamide (CPA) in combination with radiotherapy (RT) against recurrent and advanced pancreatic cancers." | 2.71 | Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer. ( Endo, S; Hashimoto, K; Higami, T; Itakura, M; Koike, M; Maruyama, R; Nio, Y; Tsuji, M; Yamaguchi, K; Yano, S, 2005) |
| " The most appropriate dosing option appeared to be 400 mg x m(-2) per day of oral UFT for 14 consecutive days with 900 mg x m(-2) gemcitabine on days 8 and 15." | 2.70 | A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer. ( Asoh, H; Ichinose, Y; Semba, H; Seto, T; Yamamoto, H; Yoh, K, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, Y | 1 |
| Hara, H | 1 |
| Tsujie, M | 1 |
| Miyamoto, A | 1 |
| Asaoka, T | 1 |
| Yamamoto, K | 1 |
| Ikenaga, M | 1 |
| Miyazaki, M | 1 |
| Ikeda, M | 1 |
| Hirao, M | 1 |
| Fujitani, K | 1 |
| Sekimoto, M | 1 |
| Nakamori, S | 1 |
| Lee, SJ | 1 |
| Cho, SH | 1 |
| Yoon, JY | 1 |
| Hwang, JE | 1 |
| Bae, WK | 1 |
| Shim, HJ | 1 |
| Chung, IJ | 1 |
| Ichinose, Y | 2 |
| Seto, T | 2 |
| Sasaki, T | 1 |
| Yamanaka, T | 1 |
| Okamoto, I | 1 |
| Takeda, K | 1 |
| Tanaka, M | 1 |
| Katakami, N | 1 |
| Sawa, T | 1 |
| Kudoh, S | 1 |
| Saka, H | 1 |
| Nishimura, Y | 1 |
| Nakagawa, K | 1 |
| Fukuoka, M | 1 |
| Nio, Y | 1 |
| Hashimoto, K | 1 |
| Yano, S | 1 |
| Itakura, M | 1 |
| Koike, M | 1 |
| Yamaguchi, K | 1 |
| Endo, S | 1 |
| Tsuji, M | 1 |
| Higami, T | 1 |
| Maruyama, R | 1 |
| Rivera, F | 1 |
| Vega-Villegas, ME | 1 |
| López-Brea, MF | 1 |
| García-Castaño, A | 1 |
| de Juan, A | 1 |
| Ramos, FJ | 1 |
| Collado, A | 1 |
| Galdós, P | 1 |
| Rubio, A | 1 |
| del Valle, A | 1 |
| Rama, J | 1 |
| Mayorga, M | 1 |
| Sanz-Ortiz, J | 1 |
| Lee, JL | 1 |
| Kang, HJ | 1 |
| Kang, YK | 1 |
| Ryu, MH | 1 |
| Chang, HM | 1 |
| Kim, TW | 1 |
| Sohn, HJ | 1 |
| Kim, H | 1 |
| Lee, JS | 1 |
| Scherrer, R | 1 |
| Geissler, K | 1 |
| Kyrle, PA | 1 |
| Gisslinger, H | 1 |
| Jäger, U | 1 |
| Bettelheim, P | 1 |
| Laczika, K | 1 |
| Locker, G | 1 |
| Scholten, C | 1 |
| Sillaber, C | 1 |
| Yoh, K | 1 |
| Asoh, H | 1 |
| Yamamoto, H | 1 |
| Semba, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for tegafur and Fever
| Article | Year |
|---|---|
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 2009 |
S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2011 |
Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap | 2005 |
Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Car | 2007 |
Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; | 2008 |
A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cel | 2002 |
2 other studies available for tegafur and Fever
| Article | Year |
|---|---|
[A Case of Subacute Thyroiditis during Chemotherapy after Distal Pancreatectomy].
Topics: Aged; Anti-Inflammatory Agents; Antimetabolites; Drug Combinations; Fatal Outcome; Female; Fever; Hu | 2016 |
Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Cell | 1993 |